Influence of dapagliflozin on cardiovascular remodeling in hypertensive patients with accompanying type 2 diabetes

被引:0
作者
Bohun, A. O. [1 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Dept Propaedeut Internal Med Radiat Diagnost & Rad, Zaporizhzhia, Ukraine
来源
PATHOLOGIA | 2024年 / 21卷 / 01期
关键词
dapagliflozin; SGLT2; inhibitors; vascular; stiffness diastolic; dysfunction; hypertension type; 2; diabetes; HEART-FAILURE; ARTERIAL STIFFNESS; DIASTOLIC FUNCTION; GUIDELINES; MELLITUS; PROFILE; IMPACT;
D O I
10.14739/2310-1237.2024.1.299196
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim. To compare the results of 12-week treatment of patients with stage II hypertension (HTN) with accompanying diabetes mellitus (DM) type 2 between the combination of metformin + dapagliflozin and metformin monotherapy by studying changes the elastic properties of the common carotid arteries (CCA), echocardiographic indicators, 24-hour ambulatory blood pressure monitoring (ABPM) and laboratory parameters of lipid and carbohydrate metabolism. Materials and methods. 24 patients with stage II HTN with type 2 DM were involved in the study, the average age 60.4 years, 50 % - men. Patients in the first group were randomized to receive metformin, and the second group - to receive combination of metformin and dapagliflozin. At inclusion and after 3 months of treatment, basic anthropometric data, laboratory indicators of lipid and carbohydrate metabolism, ABPM, echocardiography, and indicators of CCA local stiffness were studied. Statistical analysis was performed, the probability of differences is at the level of p < 0.05. Results. In both observation groups, there was a comparable decrease in SCORE 2 -Diabetes range, glucose and glycated hemoglobin, total cholesterol, LDL cholesterol, average daily systolic blood pressure (SBP), daily SBP load, day and pulse BP, as well as an increase in speed systolic movement of the lateral fibrous ring of the mitral valve (S lat). Only in the metformin + dapagliflozin group a decrease in the adipose tissue level, the average daily diastolic blood pressure (DBP), the burden of DBP, the size of the left atrium and right ventricle, an increase in the movement speeds of the medial (e'med), lateral (e'lat) ring of the mitral and of the tricuspid (e'tk) valve in the period of early diastolic filling of the ventricles, velocities of systolic movement of the medial fibrous ring of the mitral (S med) and tricuspid (S tk) valves, a decrease ratio E/e', and an improvement in the elastic properties of general carotid arteries were observed. Conclusions. In persons with HTN stage II with DM type 2 the addition of dapagliflozin to the treatment regimen was associated with better control of blood pressure, improvement of diastolic function and longitudinal contractility of the left ventricle, elastic properties of CCA.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 35 条
[1]   Carotid Artery Stiffness: Imaging Techniques and Impact on Cerebrovascular Disease [J].
Baradaran, Hediyeh ;
Gupta, Ajay .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[2]   Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center [J].
Calapkulu, Murat ;
Cander, Soner ;
Gul, Ozen Oz ;
Ersoy, Canan .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) :1031-1034
[3]   Effects of glucose control on arterial stiffness in patients with type 2 diabetes mellitus and hypertension: An observational study [J].
Chang, Sangah ;
Kim, Jihyun ;
Sohn, Taeseo ;
Son, Hyunshik ;
Lee, Jungmin .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (01) :284-292
[4]   The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis [J].
Chow, Bryan ;
Rabkin, Simon W. .
HEART FAILURE REVIEWS, 2015, 20 (03) :291-303
[5]   Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes [J].
Cinti, Francesca ;
Leccisotti, Lucia ;
Sorice, Gian Pio ;
Capece, Umberto ;
D'Amario, Domenico ;
Lorusso, Margherita ;
Gugliandolo, Shawn ;
Morciano, Cassandra ;
Guarneri, Andrea ;
Guzzardi, Maria Angela ;
Mezza, Teresa ;
Capotosti, Amedeo ;
Indovina, Luca ;
Ferraro, Pietro Manuel ;
Iozzo, Patricia ;
Crea, Filippo ;
Giordano, Alessandro ;
Giaccari, Andrea .
CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
[6]   2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD [J].
Cosentino, Francesco ;
Grant, Peter J. ;
Aboyans, Victor ;
Bailey, Clifford J. ;
Ceriello, Antonio ;
Delgado, Victoria ;
Federici, Massimo ;
Filippatos, Gerasimos ;
Grobbee, Diederick E. ;
Hansen, Tina Birgitte ;
Huikuri, Heikki, V ;
Johansson, Isabelle ;
Juni, Peter ;
Lettino, Maddalena ;
Marx, Nikolaus ;
Mellbin, Linda G. ;
Ostgren, Carl J. ;
Rocca, Bianca ;
Roffi, Marco ;
Sattar, Naveed ;
Seferovic, Petar M. ;
Sousa-Uva, Miguel ;
Valensi, Paul ;
Wheeler, David C. ;
Piepoli, Massimo Francesco ;
Birkeland, Kare, I ;
Adamopoulos, Stamatis ;
Ajjan, Ramzi ;
Avogaro, Angelo ;
Baigent, Colin ;
Brodmann, Marianne ;
Bueno, Hector ;
Ceconi, Claudio ;
Chioncel, Ovidiu ;
Coats, Andrew ;
Collet, Jean-Philippe ;
Collins, Peter ;
Cosyns, Bernard ;
Di Mario, Carlo ;
Fisher, Miles ;
Fitzsimons, Donna ;
Halvorsen, Sigrun ;
Hansen, Dominique ;
Hoes, Arno ;
Holt, Richard I. G. ;
Home, Philip ;
Katus, Hugo A. ;
Khunti, Kamlesh ;
Komajda, Michel ;
Lambrinou, Ekaterini .
EUROPEAN HEART JOURNAL, 2020, 41 (02) :255-323
[7]   Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials [J].
Feng, Miao ;
Lv, Haihong ;
Xu, Xia ;
Wang, Jue ;
Lyu, Wenyi ;
Fu, Songbo .
MEDICINE, 2019, 98 (30)
[8]   Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF [J].
Fu, Qianyu ;
Zhou, Longhua ;
Fan, Yuqin ;
Liu, Fenfen ;
Fan, Yuanyuan ;
Zhang, Xin ;
Wang, Li ;
Cheng, Lan .
BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
[9]   Beyond the Glycaemic Control of Dapagliflozin: Impact on Arterial Stiffness and Macroangiopathy [J].
Gonzalez-Clemente, Jose M. ;
Garcia-Castillo, Maria ;
Gorgojo-Martinez, Juan J. ;
Jimenez, Alberto ;
Llorente, Ignacio ;
Matute, Eduardo ;
Tejera, Cristina ;
Izarra, Aitziber ;
Lecube, Albert .
DIABETES THERAPY, 2022, 13 (07) :1281-1298
[10]   Effect of dapagliflozin on arterial stiffness in patients with type 2 diabetes mellitus [J].
Hidalgo Santiago, Juan Carlos ;
Maraver Delgado, Juan ;
Cayon Blanco, Manuel ;
Lopez Saez, Juan Bosco ;
Gomez-Fernandez, Pablo .
MEDICINA CLINICA, 2020, 154 (05) :171-174